It is important to stay up to date about the latest trends and scientific findings in the field of mental health. Here we provide you with a frequently updated RSS feed that features current news stories from the U.S. National Institute of Mental Health (NIMH). You can follow links that will take you directly to the NIMH website to read the original articles.
For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain’s executive hub. Among key findings of the study by National Institutes of Health scientists: genes implicated in schizophrenia and autism turn out to be members of a select club of genes in which regulatory activity peaks during an environmentally-sensitive critical period in development.
The NCATS Drug Rescue Program will fund research to identify new therapeutic uses of proprietary investigational drugs and biologics (Agents), made available by participating pharmaceutical partners, to improve healthcare and benefit to patients across a broad range of human diseases in areas of unmet medical need.
The purpose of this initiative is to encourage applications to develop novel technologies and/or tools to facilitate the study of genes and proteins at the synapse on a large scale.
This initiative seeks to expeditiously test and analyze novel pharmacological interventions and their molecular and/or clinical targets for treating clinical dimensions of psychopathology associated with traditional psychiatric disorders.
The 2011 Society for Neuroscience Conference was held in Washington, DC.
Dr. Insel responds to discussion from the National Advisory Mental Health Council concerning the need to balance research funding for basic science and mental health services.
Older racial and ethnic minorities living in the community are less likely to be diagnosed with depression than their white counterparts, but are also less likely to get treated, according to a recent NIMH-funded analysis published online ahead of print December 15, 2011, in the American Journal of Public Health.
NIMH’s “government bureaucrats” are really dedicated public servants devoted to good patient care, improved treatments, and scientific discovery.
The antipsychotic medication risperidone is more effective for initial treatment of mania in children diagnosed with bipolar disorder compared to other mood stabilizing medications, but it carries the potential for serious metabolic side effects, according to an NIMH-funded study published online ahead of print January 2, 2012, in the Archives of General Psychiatry.
On December 23, 2011, NIMH Director Thomas R. Insel, M.D., was formally designated acting director of the newly established National Center for Advancing Translational Sciences (NCATS) at NIH.